|Day's Range||169.53 - 170.12|
|52 Week Range||137.30 - 170.56|
|PE Ratio (TTM)||-26.76|
|Expense Ratio (net)||0.44%|
As discussed earlier, Johnson & Johnson (JNJ) reported an increase of ~2.9% in revenue to $18.8 billion in 2Q17, compared with $18.5 billion in 2Q16. The above graph compares the…
Johnson & Johnson continued its long streak of earnings beat and offered an upbeat outlook for the full year. However, it lagged our revenue estimate.
Allergan’s (AGN) US Specialized Therapeutics segment includes branded products from a range of therapeutic areas.